XML 74 R2.htm IDEA: XBRL DOCUMENT v3.22.4

Pay vs Performance Disclosure

12 Months Ended

Jan. 01, 2023

USD ($)

$ / shares

Jan. 02, 2022

USD ($)

$ / shares

Jan. 03, 2021

USD ($)

$ / shares

Pay vs Performance Disclosure [Table]

Pay vs Performance [Table Text Block]

A			B			C			D			E			F			G			H			I			J
															Value of Initial Fixed $100 Investment Based On:
Year			Summary Compensation Table Total for PEO			Compensation Actually Paid to PEO			Average Summary Compensation Table Total for non-PEO NEOs			Average Compensation Actually Paid to non-PEO NEOs			Total Shareholder Return			Peer Group Total Shareholder Return (S&P Pharmaceuticals Sub Index)			Peer Group Total Shareholder Return (S&P Healthcare Equipment Sub Index)			Net Income ($millions)			Annual Relative Total Shareholder Return  (% points)
2022			$13,099,487			$18,910,984			$8,021,796			$11,882,576			$130.91			$146.65			$113.92			17,941			5.6		%
2021			26,741,959			39,418,762			12,498,029			16,589,485			123.54			135.21			140.40			20,878			(2.4)
2020			29,575,974			28,993,387			12,948,370			11,481,072			110.85			107.53			117.63			14,714			1.6

Named Executive Officers, Footnote [Text Block]

Column B includes the amounts reported in the Total column of the Summary Compensation Table for our CEO. Column D includes the average of the amounts reported in the Total column of the Summary Compensation Table for our named executive officers excluding our CEO.

In the table below, we show which executives were included in columns B through E in 2020-2022.

Executive Name

PEO

Non-PEO NEO

2020

2021

2022

2020

2021

2022

A. Gorsky

X

X

J. Duato

X

X

X

J. Wolk

X

X

X

P. Stoffels

X

X

J. Taubert

X

X

X

A. McEvoy

X

T. Mongon

X

It is important to keep in mind that our CEO and named executive officers have changed, making year-to-year comparisons of Compensation Actually Paid difficult. Most significant is our change in CEO. For 2020 and 2021, Mr. Gorsky was our CEO (PEO in the table) and for 2022 Mr. Duato was our CEO

Peer Group Issuers, Footnote [Text Block]

Competitor Composite Peer Group
Pharmaceuticals			MedTech			Consumer Health
AbbVie Inc			Alcon			Beiersdorf AG
Amgen Inc			Boston Scientific Corp			Colgate-Palmolive Co
AstraZeneca PLC			Cooper Cos Inc			L'Oreal SA
Bristol-Myers Squibb Co			The Intuitive Surgical			Procter & Gamble Co
Eli Lilly & Co			Medtronic Inc			The Reckitt Benckiser
GlaxoSmithKline PLC			Smith & Nephew PLC			Unilever
Merck & Co Inc			Stryker Corp
Novartis AG			Zimmer Holdings Inc
Pfizer Inc
Roche Holding AG
Sanofi

PEO Total Compensation Amount

$ 13,099,487

$ 26,741,959

$ 29,575,974

PEO Actually Paid Compensation Amount

$ 18,910,984

39,418,762

28,993,387

Adjustment To PEO Compensation, Footnote [Text Block]

Year			Year-End Fair Value of Equity Awards Granted During Applicable Year			Change in Fair Value as of Year-End of Any Prior-Year Awards that Remain Unvested as of Year-End			Change in Fair Value as of the Vesting Date of Any Prior -Year Awards that Vested During Applicable Year			Pay Versus Performance Value of Equity Awards
PEO
2022			$10,012,527			$4,005,011			$(420,254)			$13,597,284
2021			21,784,640			7,510,917			2,928,188			32,223,745
2020			17,452,777			3,954,446			2,158,449			23,565,672
Average of Non-PEO NEOs
2022			7,204,994			2,486,599			(201,362)			9,490,231
2021			8,964,136			3,045,440			836,235			12,845,811
2020			7,143,024			1,311,996			599,228			9,054,248

Year			Service Costs Attributable to the Applicable Year			Prior Service Costs Introduced During the Applicable Year			Pay Versus Performance Value of Pension Benefits
PEO
2022			$474,001			$0			$474,001
2021			988,230			0			988,230
2020			948,152			(519,762)			428,390
Average of Other NEOs
2022			329,779			0			329,779
2021			575,029			0			575,029
2020			423,888			(533,939)			(110,051)

Non-PEO NEO Average Total Compensation Amount

$ 8,021,796

12,498,029

12,948,370

Non-PEO NEO Average Compensation Actually Paid Amount

$ 11,882,576

16,589,485

11,481,072

Adjustment to Non-PEO NEO Compensation Footnote [Text Block]

The following table shows adjustments made to total compensation for each year to determine the Compensation Actually Paid:

Year			Summary Compensation Table Total			Minus Summary Compensation Table Value of Equity Awards			Plus Pay Versus Performance Value of Equity Awards			Minus Summary Compensation Table Change in the Actuarial Present Value of Pension Benefits			Plus Pay Versus Performance Value of Pension Benefits			Equals Compensation Actually Paid
PEO
2022			$13,099,487			$8,259,788			$13,597,284			$0			$474,001			$18,910,984
2021			26,741,959			19,859,172			32,223,745			676,000			988,230			39,418,762
2020			29,575,974			18,140,649			23,565,672			6,436,000			428,390			28,993,387
Average of Non-PEO NEOs
2022			8,021,796			5,943,730			9,490,231			15,500			329,779			11,882,576
2021			12,498,029			8,169,384			12,845,811			1,160,000			575,029			16,589,485
2020			12,948,370			7,411,495			9,054,248			3,000,000			(110,051)			11,481,072

Year			Year-End Fair Value of Equity Awards Granted During Applicable Year			Change in Fair Value as of Year-End of Any Prior-Year Awards that Remain Unvested as of Year-End			Change in Fair Value as of the Vesting Date of Any Prior -Year Awards that Vested During Applicable Year			Pay Versus Performance Value of Equity Awards
PEO
2022			$10,012,527			$4,005,011			$(420,254)			$13,597,284
2021			21,784,640			7,510,917			2,928,188			32,223,745
2020			17,452,777			3,954,446			2,158,449			23,565,672
Average of Non-PEO NEOs
2022			7,204,994			2,486,599			(201,362)			9,490,231
2021			8,964,136			3,045,440			836,235			12,845,811
2020			7,143,024			1,311,996			599,228			9,054,248

Year			Service Costs Attributable to the Applicable Year			Prior Service Costs Introduced During the Applicable Year			Pay Versus Performance Value of Pension Benefits
PEO
2022			$474,001			$0			$474,001
2021			988,230			0			988,230
2020			948,152			(519,762)			428,390
Average of Other NEOs
2022			329,779			0			329,779
2021			575,029			0			575,029
2020			423,888			(533,939)			(110,051)

Compensation Actually Paid vs. Total Shareholder Return [Text Block]

The chart below compares the Compensation Actually Paid to our CEO and the average of our other NEOs with the Company’s cumulative TSR.

As described on page 70, three-year TSR relative to our Competitor Composite Peers is one of our PSU performance measures. However, the Company’s cumulative TSR without a peer comparison is not one of the performance measures we use in our annual or long-term incentive plans.

The Company’s cumulative TSR includes both our annual share price appreciation and the impact of reinvested dividends. Because most of our executives’ compensation is equity-based long-term incentives which vary in value with the Company’s price, our CAP is aligned with the annual share price appreciation component of TSR. Dividends confound the relationship because they are included in the cumulative TSR but are not included in CAP because we do not pay dividends on unvested equity awards.

Compensation Actually Paid vs. Net Income [Text Block]

The chart below compares the Compensation Actually Paid to our CEO and the average of our other NEOs with the Company’s net income.

As described on pages 67 and 70, adjusted operational EPS is one of our annual incentive measures and three-year cumulative adjusted operational EPS is one of our PSU performance measures. These measures are compared to goals that we set at the beginning of each year for the annual incentives and at the beginning of each 3-year performance period for the PSUs.

While annual net income impacts our adjusted operational EPS and three-year cumulative adjusted operational EPS, it is not one of the performance measures we use in our annual or long-term incentive plans. Therefore, any relationship of CAP with the Company’s annual net income would be indirect, at best, because it is not a performance measure in our compensation program and it is not compared to any goals.

Compensation Actually Paid vs. Company Selected Measure [Text Block]

The chart below compares the Compensation Actually Paid to our CEO and the average of our other NEOs with the Company’s annual relative TSR.

Annual relative TSR directly impacts the three overlapping PSU performance cycles that are outstanding each year. Higher annual relative TSR increases the fair value of the outstanding PSUs and conversely lower annual relative TSR decreases the fair value of outstanding PSUs.

Performance against our annual incentive goals, three-year cumulative adjusted operational EPS PSU goals, and changes in the fair value of long-term incentive awards granted each year confound the relationship of CAP and annual relative TSR because they are independent of annual relative TSR.

Note: we use three-year relative TSR as a PSU performance measure. However, SEC guidance limits the measures to one-year periods.

Annual Relative TSR
TSR			2020			2021			2022
Johnson & Johnson			9.3		%	12.8		%	8.0		%
Competitor Composite			7.7			15.2			2.4
One-Year Relative TSR			1.6			(2.4)			5.6

The TSR for each of the three business groups within the Competitor Composite Peer Group is weighted based on the Company’s sales mix for the prior year as shown in the table below.

Competitor Composite Peer Group Weightings
Business Group			2020			2021			2022
Pharmaceuticals			51.4		%	54.7		%	55.1		%
MedTech			31.6			27.8			28.9
Consumer Health			16.9			17.5			16.0
Total			100.0			100.0			100.0

Total Shareholder Return Vs Peer Group [Text Block]

The chart below compares the Company's cumulative TSR over the three years presented in the table with the cumulative TSR of our two peer indices: the S&P Pharmaceuticals Index and the S&P Healthcare Equipment Index.

We do not use the cumulative TSR of the S&P Pharmaceuticals Index or S&P Healthcare Equipment index as incentive measures for our NEOs. However, we do measure three-year relative TSR versus our Competitor Composite Peer Group as one of our PSU metrics, as described in greater detail in our PSU Goal Setting Process on page 70. So, the relationship of CAP with our three-year relative TSR versus our Competitor Composite Peer Group is direct for each of the overlapping PSU performance periods shown in the table.

Tabular List [Table Text Block]

			Annual Incentive Financial Performance Measures						Long-Term Incentive  Financial Performance Measures
l			Operational Sales			l			Three-Year Cumulative Adjusted Operational EPS
l			Adjusted Operational EPS Growth			l			Three-Year TSR Compound Annual Growth Rate versus the Competitor Composite Peer Group
l			Free Cash Flow			l			Share Price
						l			Share Price Appreciation

Total Shareholder Return Amount

$ 130.91

123.54

110.85

Peer Group Total Shareholder Return Amount

146.65

135.21

107.53

Net Income (Loss)

$ 17,941,000,000

$ 20,878,000,000

$ 14,714,000,000

Company Selected Measure Amount

0.056

(0.024)

0.016

Peer Group Total Shareholder Return Amount, Two | $ / shares

$ 113.92

$ 140.40

$ 117.63

Measure [Axis]: 1

Pay vs Performance Disclosure [Table]

Measure Name

Operational Sales

Measure [Axis]: 2

Pay vs Performance Disclosure [Table]

Measure Name

Adjusted Operational EPS Growth

Measure [Axis]: 3

Pay vs Performance Disclosure [Table]

Measure Name

Free Cash Flow

Measure [Axis]: 4

Pay vs Performance Disclosure [Table]

Measure Name

Three-Year Cumulative Adjusted Operational EPS

Measure [Axis]: 5

Pay vs Performance Disclosure [Table]

Measure Name

Three-Year TSR Compound Annual Growth Rate versus the Competitor Composite Peer Group

Measure [Axis]: 6

Pay vs Performance Disclosure [Table]

Measure Name

Share Price

Measure [Axis]: 7

Pay vs Performance Disclosure [Table]

Measure Name

Share Price Appreciation

PEO [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount

$ 474,001

$ 988,230

$ 428,390

PEO [Member] | Exclusion of Equity Awards [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount

8,259,788

19,859,172

18,140,649

PEO [Member] | Equity Award Adjustments [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount

13,597,284

32,223,745

23,565,672

PEO [Member] | Exclusion of Change in Pension Benefit [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount

0

676,000

6,436,000

PEO [Member] | Inclusion of Pension Benefit [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount

474,001

988,230

428,390

PEO [Member] | Equity Awards Granted During the Year [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount, Equity Awards

10,012,527

21,784,640

17,452,777

PEO [Member] | Equity Awards Granted in Prior Years, Unvested [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount, Equity Awards

4,005,011

7,510,917

3,954,446

PEO [Member] | Equity Awards Granted in Prior Years, Vested [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount, Equity Awards

(420,254)

2,928,188

2,158,449

PEO [Member] | Inclusion of Pension Service Costs [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount

474,001

988,230

948,152

PEO [Member] | Inclusion of Prior Year Pension Service Cost [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount

0

0

(519,762)

Non-PEO NEO [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount

329,779

575,029

(110,051)

Non-PEO NEO [Member] | Exclusion of Equity Awards [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount

5,943,730

8,169,384

7,411,495

Non-PEO NEO [Member] | Equity Award Adjustments [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount

9,490,231

12,845,811

9,054,248

Non-PEO NEO [Member] | Exclusion of Change in Pension Benefit [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount

15,500

1,160,000

3,000,000

Non-PEO NEO [Member] | Inclusion of Pension Benefit [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount

329,779

575,029

(110,051)

Non-PEO NEO [Member] | Equity Awards Granted During the Year [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount, Equity Awards

7,204,994

8,964,136

7,143,024

Non-PEO NEO [Member] | Equity Awards Granted in Prior Years, Unvested [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount, Equity Awards

2,486,599

3,045,440

1,311,996

Non-PEO NEO [Member] | Equity Awards Granted in Prior Years, Vested [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount, Equity Awards

(201,362)

836,235

599,228

Non-PEO NEO [Member] | Inclusion of Pension Service Costs [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount

329,779

575,029

423,888

Non-PEO NEO [Member] | Inclusion of Prior Year Pension Service Cost [Member]

Pay vs Performance Disclosure [Table]

Adjustment to Compensation Amount

$ 0

$ 0

$ (533,939)

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 3

+ Details

Name:	ecd_AdjToCompAmt
Namespace Prefix:	ecd_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 3

+ Details

Name:	ecd_AdjToNonPeoNeoCompFnTextBlock
Namespace Prefix:	ecd_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 3

+ Details

Name:	ecd_AdjToPeoCompFnTextBlock
Namespace Prefix:	ecd_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 2
-Subparagraph vi

+ Details

Name:	ecd_CoSelectedMeasureAmt
Namespace Prefix:	ecd_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 5
-Subparagraph iii

+ Details

Name:	ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock
Namespace Prefix:	ecd_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 5
-Subparagraph ii

+ Details

Name:	ecd_CompActuallyPaidVsNetIncomeTextBlock
Namespace Prefix:	ecd_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 5
-Subparagraph i

+ Details

Name:	ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock
Namespace Prefix:	ecd_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 2
-Subparagraph vi

+ Details

Name:	ecd_MeasureName
Namespace Prefix:	ecd_
Data Type:	xbrli:normalizedStringItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 3

+ Details

Name:	ecd_NamedExecutiveOfficersFnTextBlock
Namespace Prefix:	ecd_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 2
-Subparagraph iii

+ Details

Name:	ecd_NonPeoNeoAvgCompActuallyPaidAmt
Namespace Prefix:	ecd_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 2
-Subparagraph ii

+ Details

Name:	ecd_NonPeoNeoAvgTotalCompAmt
Namespace Prefix:	ecd_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 2
-Subparagraph iv

+ Details

Name:	ecd_PeerGroupIssuersFnTextBlock
Namespace Prefix:	ecd_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 2
-Subparagraph iv

+ Details

Name:	ecd_PeerGroupTotalShareholderRtnAmt
Namespace Prefix:	ecd_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 2
-Subparagraph iii

+ Details

Name:	ecd_PeoActuallyPaidCompAmt
Namespace Prefix:	ecd_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 2
-Subparagraph ii

+ Details

Name:	ecd_PeoTotalCompAmt
Namespace Prefix:	ecd_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 1

+ Details

Name:	ecd_PvpTable
Namespace Prefix:	ecd_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 1

+ Details

Name:	ecd_PvpTableTextBlock
Namespace Prefix:	ecd_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 6

+ Details

Name:	ecd_TabularListTableTextBlock
Namespace Prefix:	ecd_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 2
-Subparagraph iv

+ Details

Name:	ecd_TotalShareholderRtnAmt
Namespace Prefix:	ecd_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	duration

X

- References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K
-Number 229
-Section 402
-Subsection v
-Paragraph 5
-Subparagraph iv

+ Details

Name:	ecd_TotalShareholderRtnVsPeerGroupTextBlock
Namespace Prefix:	ecd_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	jnj_AdjustmentToCompensationAmountEquityAwards
Namespace Prefix:	jnj_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	jnj_PeerGroupTotalShareholderReturnAmountTwo
Namespace Prefix:	jnj_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

+ Details

Name:	us-gaap_NetIncomeLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	ecd_MeasureAxis=1
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_MeasureAxis=2
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_MeasureAxis=3
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_MeasureAxis=4
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_MeasureAxis=5
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_MeasureAxis=6
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_MeasureAxis=7
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_ExecutiveCategoryAxis=ecd_PeoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_AdjToCompAxis=jnj_ExclusionOfEquityAwardsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_AdjToCompAxis=jnj_EquityAwardAdjustmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_AdjToCompAxis=jnj_ExclusionOfChangeInPensionBenefitMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_AdjToCompAxis=jnj_InclusionOfPensionBenefitMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_AdjToCompAxis=jnj_EquityAwardsGrantedDuringTheYearMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_AdjToCompAxis=jnj_EquityAwardsGrantedInPriorYearsUnvestedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_AdjToCompAxis=jnj_EquityAwardsGrantedInPriorYearsVestedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_AdjToCompAxis=jnj_InclusionOfPensionServiceCostsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_AdjToCompAxis=jnj_InclusionOfPriorYearPensionServiceCostMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: